{"id":"https://openalex.org/W2546503501","doi":"https://doi.org/10.1111/liv.13298","title":"The value of cure associated with treating treatment\u2010na\u00efve chronic hepatitis C genotype 1: Are the new all\u2010oral regimens good value to society?","display_name":"The value of cure associated with treating treatment\u2010na\u00efve chronic hepatitis C genotype 1: Are the new all\u2010oral regimens good value to society?","publication_year":2016,"publication_date":"2016-11-29","ids":{"openalex":"https://openalex.org/W2546503501","doi":"https://doi.org/10.1111/liv.13298","mag":"2546503501","pmid":"https://pubmed.ncbi.nlm.nih.gov/27804195"},"language":"en","primary_location":{"id":"doi:10.1111/liv.13298","doi":"https://doi.org/10.1111/liv.13298","is_oa":false,"landing_page_url":"https://doi.org/10.1111/liv.13298","pdf_url":null,"source":{"id":"https://openalex.org/S206392846","display_name":"Liver International","issn_l":"0106-9543","issn":["0106-9543","1478-3223","1478-3231","1600-0676"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Liver International","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080386622","display_name":"Zobair M. Younossi","orcid":"https://orcid.org/0000-0001-9313-577X","observed_orcids":["https://orcid.org/0000-0001-9313-577X"]},"institutions":[{"id":"https://openalex.org/I116530498","display_name":"Inova Health System","ror":"https://ror.org/04mrb6c22","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I116530498"]},{"id":"https://openalex.org/I2800468613","display_name":"Inova Fairfax Hospital","ror":"https://ror.org/0212h5y77","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I116530498","https://openalex.org/I2800468613"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Zobair M. Younossi","raw_affiliation_strings":["Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA","Center for Liver Disease, Department of Medicine, Inova Fairfax Hospital, Falls Church, VA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA","institution_ids":["https://openalex.org/I116530498"]},{"raw_affiliation_string":"Center for Liver Disease, Department of Medicine, Inova Fairfax Hospital, Falls Church, VA, USA","institution_ids":["https://openalex.org/I2800468613"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075594125","display_name":"Haesuk Park","orcid":"https://orcid.org/0000-0003-3299-8111","observed_orcids":["https://orcid.org/0000-0003-3299-8111"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Haesuk Park","raw_affiliation_strings":["University of Florida, Gainesville, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Florida, Gainesville, FL, USA","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024836953","display_name":"Douglas T. Dieterich","orcid":"https://orcid.org/0000-0001-7786-8594","observed_orcids":["https://orcid.org/0000-0001-7786-8594"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Douglas Dieterich","raw_affiliation_strings":["Mount Sinai Medical Center, New York City, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mount Sinai Medical Center, New York City, NY, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078234841","display_name":"Sammy Saab","orcid":"https://orcid.org/0000-0003-3346-9297","observed_orcids":["https://orcid.org/0000-0003-3346-9297"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sammy Saab","raw_affiliation_strings":["University of California Los Angeles, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California Los Angeles, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079801760","display_name":"Aijaz Ahmed","orcid":"https://orcid.org/0000-0002-3609-8586","observed_orcids":["https://orcid.org/0000-0002-3609-8586"]},"institutions":[{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aijaz Ahmed","raw_affiliation_strings":["Stanford University, Stanford, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stanford University, Stanford, CA, USA","institution_ids":["https://openalex.org/I97018004"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046835105","display_name":"Stuart C. Gordon","orcid":"https://orcid.org/0000-0001-8666-3849","observed_orcids":["https://orcid.org/0000-0001-8666-3849"]},"institutions":[{"id":"https://openalex.org/I2803043754","display_name":"Henry Ford Hospital","ror":"https://ror.org/0193sb042","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I154057602","https://openalex.org/I2803043754"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stuart C. Gordon","raw_affiliation_strings":["Henry Ford Hospital, Detroit, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Henry Ford Hospital, Detroit, MI, USA","institution_ids":["https://openalex.org/I2803043754"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5080386622"],"corresponding_institution_ids":["https://openalex.org/I116530498","https://openalex.org/I2800468613"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":4.0963,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":{"value":0.94413463,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"37","issue":"5","first_page":"662","last_page":"668"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.9014000296592712,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.9014000296592712,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.09759999811649323,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-hepatitis-c","display_name":"chronic hepatitis C","score":0.9599999785423279},{"id":"https://openalex.org/keywords/hcv-genotype-1","display_name":"HCV genotype 1","score":0.9049999713897705},{"id":"https://openalex.org/keywords/all-oral-antiviral-therapy","display_name":"all-oral antiviral therapy","score":0.8500000238418579},{"id":"https://openalex.org/keywords/sofosbuvir","display_name":"sofosbuvir","score":0.7379999756813049},{"id":"https://openalex.org/keywords/simeprevir","display_name":"simeprevir","score":0.8460000157356262},{"id":"https://openalex.org/keywords/ledipasvir-sofosbuvir","display_name":"ledipasvir/sofosbuvir","score":0.9599999785423279},{"id":"https://openalex.org/keywords/pegylated-interferon","display_name":"pegylated interferon","score":0.6890000104904175},{"id":"https://openalex.org/keywords/ribavirin","display_name":"ribavirin","score":0.9929999709129333},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.8949999809265137},{"id":"https://openalex.org/keywords/cost-reduction","display_name":"cost reduction","score":0.6700000166893005},{"id":"https://openalex.org/keywords/liver-cirrhosis","display_name":"liver cirrhosis","score":0.6549999713897705},{"id":"https://openalex.org/keywords/treatment-naive-patients","display_name":"treatment-naive patients","score":0.7870000004768372},{"id":"https://openalex.org/keywords/markov-model","display_name":"Markov model","score":0.6480000019073486}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8755501508712769},{"id":"https://openalex.org/C2778390639","wikidata":"https://www.wikidata.org/wiki/Q2502747","display_name":"Sofosbuvir","level":5,"score":0.8660417199134827},{"id":"https://openalex.org/C2778867932","wikidata":"https://www.wikidata.org/wiki/Q16824572","display_name":"Paritaprevir","level":5,"score":0.8269885778427124},{"id":"https://openalex.org/C2778785139","wikidata":"https://www.wikidata.org/wiki/Q19462214","display_name":"Dasabuvir","level":5,"score":0.7953755855560303},{"id":"https://openalex.org/C2777100407","wikidata":"https://www.wikidata.org/wiki/Q19598175","display_name":"Ombitasvir","level":5,"score":0.7924344539642334},{"id":"https://openalex.org/C2775999097","wikidata":"https://www.wikidata.org/wiki/Q15409409","display_name":"Ledipasvir","level":5,"score":0.7918339967727661},{"id":"https://openalex.org/C2778986448","wikidata":"https://www.wikidata.org/wiki/Q7517689","display_name":"Simeprevir","level":5,"score":0.7675532102584839},{"id":"https://openalex.org/C2780040827","wikidata":"https://www.wikidata.org/wiki/Q421862","display_name":"Ribavirin","level":4,"score":0.6560550928115845},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5819451808929443},{"id":"https://openalex.org/C2779298103","wikidata":"https://www.wikidata.org/wiki/Q422618","display_name":"Ritonavir","level":5,"score":0.5414173603057861},{"id":"https://openalex.org/C2776455275","wikidata":"https://www.wikidata.org/wiki/Q154869","display_name":"Hepatitis C","level":2,"score":0.49880027770996094},{"id":"https://openalex.org/C2776979040","wikidata":"https://www.wikidata.org/wiki/Q5207712","display_name":"Daclatasvir","level":5,"score":0.43893784284591675},{"id":"https://openalex.org/C2776461080","wikidata":"https://www.wikidata.org/wiki/Q7160835","display_name":"Pegylated interferon","level":5,"score":0.41969209909439087},{"id":"https://openalex.org/C2776408679","wikidata":"https://www.wikidata.org/wiki/Q708693","display_name":"Hepatitis C virus","level":3,"score":0.30696815252304077},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.24364733695983887},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.19133591651916504},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.08486956357955933},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000069474","descriptor_name":"Sofosbuvir","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000069616","descriptor_name":"Simeprevir","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000072230","descriptor_name":"Sustained Virologic Response","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003657","descriptor_name":"Decision Making","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D005449","descriptor_name":"Fluorenes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008103","descriptor_name":"Liver Cirrhosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008103","descriptor_name":"Liver Cirrhosis","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D008390","descriptor_name":"Markov Chains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012254","descriptor_name":"Ribavirin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014542","descriptor_name":"Uridine Monophosphate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014542","descriptor_name":"Uridine Monophosphate","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D016174","descriptor_name":"Hepacivirus","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D019057","descriptor_name":"Quality-Adjusted Life Years","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019698","descriptor_name":"Hepatitis C, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/liv.13298","doi":"https://doi.org/10.1111/liv.13298","is_oa":false,"landing_page_url":"https://doi.org/10.1111/liv.13298","pdf_url":null,"source":{"id":"https://openalex.org/S206392846","display_name":"Liver International","issn_l":"0106-9543","issn":["0106-9543","1478-3223","1478-3231","1600-0676"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Liver International","raw_type":"journal-article"},{"id":"pmid:27804195","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27804195","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Liver international : official journal of the International Association for the Study of the Liver","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320308573","display_name":"Gilead Sciences","ror":"https://ror.org/056546b03"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W1512398135","https://openalex.org/W1523239401","https://openalex.org/W1583807094","https://openalex.org/W1744400852","https://openalex.org/W1910533708","https://openalex.org/W1961225815","https://openalex.org/W1991395575","https://openalex.org/W1994614779","https://openalex.org/W2015763165","https://openalex.org/W2015819742","https://openalex.org/W2027792646","https://openalex.org/W2042063433","https://openalex.org/W2043193067","https://openalex.org/W2045245188","https://openalex.org/W2050678963","https://openalex.org/W2051027258","https://openalex.org/W2058056848","https://openalex.org/W2061365719","https://openalex.org/W2065146174","https://openalex.org/W2067182451","https://openalex.org/W2067715515","https://openalex.org/W2078450406","https://openalex.org/W2078799829","https://openalex.org/W2081689022","https://openalex.org/W2081897332","https://openalex.org/W2095348495","https://openalex.org/W2114965058","https://openalex.org/W2122697393","https://openalex.org/W2127497497","https://openalex.org/W2132492420","https://openalex.org/W2133036275","https://openalex.org/W2151113297","https://openalex.org/W2156047379","https://openalex.org/W2433875347","https://openalex.org/W2506138158","https://openalex.org/W2520731166"],"related_works":["https://openalex.org/W2120421547","https://openalex.org/W2530848529","https://openalex.org/W2604398860","https://openalex.org/W1991395575","https://openalex.org/W4395052315","https://openalex.org/W1775558726","https://openalex.org/W2180414399","https://openalex.org/W2344127677","https://openalex.org/W3111214039","https://openalex.org/W2235149922"],"abstract_inverted_index":{"BACKGROUND":[0],"&":[1],"AIMS:":[2],"All-oral":[3],"regimens":[4,171,184,200,234],"are":[5],"associated":[6,123],"with":[7,67,124,143,195,222],"high":[8],"cure":[9,26,110,194],"rates":[10,73],"in":[11,116,135,150],"hepatitis":[12],"C":[13],"virus-genotype":[14],"1":[15],"(HCV-GT1)":[16],"patients.":[17],"Our":[18],"aim":[19],"was":[20,111,201],"to":[21,27,160,173,225],"assess":[22],"the":[23,28,114,117,120,136],"value":[24,108,167,192,242],"of":[25,86,109,168,175,182,193,233,243],"society":[29],"for":[30,37,91,218,235],"treating":[31],"HCV":[32,236],"infection.":[33],"METHODS:":[34],"Markov":[35],"model":[36,52],"HCV-GT1":[38,87,133,141,219],"projected":[39],"long-term":[40],"health":[41],"outcomes,":[42],"life":[43,47],"years,":[44],"and":[45,59,61,64,84,94,100,146,153,178,188,198,204,241],"quality-adjusted":[46],"years":[48],"(QALYs)":[49],"gained.":[50],"The":[51,107,191,230],"compared":[53,159,224],"second-generation":[54,92,144,196],"triple":[55,93,145,197],"(sofosbuvir+pegylated":[56],"interferon+ribavirin":[57],"[PR]":[58],"simeprevir+PR)":[60],"all-oral":[62,95,147,199],"(ledipasvir/sofosbuvir":[63],"ombitasvir+paritaprevir/ritonavir+dasabuvir\u00b1ribavirin)":[65],"therapies":[66,148],"no":[68,161],"treatment.":[69],"Sustained":[70],"virological":[71],"response":[72],"were":[74,89,102,185,216],"based":[75,103],"on":[76,104],"Phase":[77],"III":[78],"RCTs.":[79],"We":[80],"assumed":[81,210],"that":[82],"80%":[83],"95%":[85],"patients":[88,134,142,226],"eligible":[90,140],"regimens.":[96],"Transition":[97],"probabilities,":[98],"utility":[99],"mortality":[101],"literature":[105],"review.":[106],"calculated":[112],"by":[113],"difference":[115],"savings":[118,174,215],"from":[119],"economic":[121],"gains":[122],"additional":[125,156],"QALYs.":[126],"RESULTS:":[127],"Model":[128],"estimated":[129],"1.52":[130],"million":[131,152,155],"treatment-na\u00efve":[132],"US.":[137],"Treating":[138],"all":[139],"resulted":[149],"3.2":[151],"4.8":[154],"QALYs":[157],"gained":[158],"treatment":[162],"respectively.":[163],"Using":[164],"$50,000":[165],"as":[166],"QALY,":[169],"these":[170,183],"lead":[172],"$185":[176],"billion":[177,187,203],"$299":[179],"billion;":[180],"costs":[181],"$109":[186],"$128":[189],"billion.":[190],"$55":[202],"$111":[205],"billion,":[206],"when":[207],"we":[208],"conservatively":[209],"only":[211],"drug":[212],"costs.":[213],"Cost":[214],"greater":[217],"patient":[220],"cured":[221],"cirrhosis":[223],"without":[227],"cirrhosis.":[228],"CONCLUSIONS:":[229],"recent":[231],"evolution":[232],"GT1":[237],"has":[238],"increased":[239],"efficacy":[240],"cure.":[244]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-11-11T00:00:00"}